Saba blocks Edinburgh Worldwide tender
The £813m Baillie Gifford trust will now pursue the activist’s alternative tender plan after today’s ‘very disappointing outcome’.
Edinburgh Worldwide tender blocked
Edinburgh Worldwide has announced that shareholders have voted 53.8% to 46.2% to block the proposed tender, and this will now not go ahead. The turnou...
3i slump drags Mercantile below benchmark
Large holdings in alternative asset managers caused the greatest damage to performance last year.
Probe launched into PwC audit of collapsed Digital 9 Infra
Analysts expect a 75% write down in its NAV per share in its next update.
Impax AM shares crash as loss of Environmental Markets trust heightens concern over asset outflows
Shares in Impax Asset Management (IPX) plunged 25% today after investors reacted to further outflows from the sustainable investment group worsened by...
GRID delays £150m earnings target as connection dates move
The update means four of the battery storage trust's five pipeline projects now have confirmed energisation dates.
Mercantile rues missing out on 2025’s “mid-cap” bid bonanza
Mercantile (MRC), JPMorgan’s £1.7bn UK “mid-cap” investment trust, underperformed in the year to 31 January as the portfolio missed out on most of the...
Gresham House Energy Storage delays £150m earnings target after two battery projects get 2029 connection dates
Gresham House Energy Storage Fund (GRID) will not hit its £150m earnings target by the end of next year after the National Electricity System Operator...
Accountancy watchdog probes PwC audit of DGI9’s 2023 results that were written down by 57% a year later
The Financial Reporting Council has begun an investigation into the audit by PricewaterhouseCoopers of the 2023 results of Digital 9 Infrastructure (D...
Morning briefing: Franklin Templeton brings Uzbekistan fund to London; plus Aurora UK, Capital Gearing, Unite, Fair Oaks, Supermarket Income
UzNIF, the $2.4bn National Investment Fund of the Republic of Uzbekistan managed by Franklin Templeton, has declared its intention to float on the Lon...
Will hawkish central banks derail biotech's bounce back?
Fears that delayed interest rate cuts could scupper biotech’s long-awaited recovery may be overstated, according to RTW’s Oliver Kenyon.
Dunedin eases ESG exclusions after another year of poor returns
Analysts estimate sustainability restraints inflicted a 5% blow to performance last year, but warned the shift may come too late.
Developed by Moore-Wilson
Follow us
